Videos

Bringing Stakeholders Together Bringing Stakeholders Together

September 28, 2023

March 22, 2023

Navigating Care Programs in the Post-OCM era

March 7, 2023

Tackling Health Equity in Oncology

December 14, 2022

Relapsed or Refractory FL: Best Practices for Active Surveillance & Reinforcement of Management Plans

$Relapsed or Refractory FL: Best Practices for Active Surveillance & Reinforcement of Management Plans$

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

October 4, 2022

Predicting High-Risk Disease Using Progression of Disease in 24 Months (POD24) and the Key Role of Repeat Biopsy to Exclude the Diagnosis of Transformation to a High-Grade Lymphoma in Patients with Relapsed Follicular Lymphoma

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

September 23, 2022

Broadening the Variety of Candidate Therapies for R/R Follicular Lymphoma Allows Optimal Personalized Rx Choice, While Patient-Directed Education Helps Attain Greatest Clinical Benefit

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

September 19, 2022

Criteria Used to Guide Treatment Decisions and Choice of Therapeutic Agents in Patients with Relapsed or Refractory Follicular Lymphoma

$Criteria Used to Guide Treatment Decisions and Choice of Therapeutic Agents in Patients with Relapsed or Refractory Follicular Lymphoma$

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

September 12, 2022

Specific Dysregulation of B-Cell Signaling in Follicular Lymphoma and Its Role in the Initiation and Progression of This Malignancy

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

September 6, 2022

Spectrum of Symptoms in Patients Newly Diagnosed with Follicular Lymphoma and the Role of Optimal Coordination of Care at Initial Presentation

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

August 31, 2022

Epidemiology and expected survivorship in follicular lymphoma and lack of reliable long-term outcome predictors at disease presentation

FEATURING:

Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD

August 23, 2022

The Future of Accelerated Approval: Evolving to Better Serve Cancer Patients

FEATURING:

Tracy Baroni-Allmon, BS Pharm, JD; Andrea Ferris, MBA; Ryan Hohma, JD; Paul Jeffrey, PharmD; Robert Orlowski, MD, PhD; Andrew Robertson, PhD, JD; Nicholas J. Sarlis, MD, PhD, FACP

June 8, 2022

How oncologists can control costs at the point of care

FEATURING:

Ajeet Gajra, MD, FACP; Stephanie Mayfield, PharmD; Kathy Oubre, MS; Tanya Park

March 14, 2022

Navigation Is About Value

FEATURING:

Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

December 30, 2021

AVBCC